立体定向放射外科用于老年及高龄脑转移患者以减少全脑放疗相关毒性
该回顾性研究纳入2010至2015年Johns Hopkins医院119例接受放疗的老年(70-79岁)及高龄(≥80岁)脑转移患者,比较 upfront WBRT 与 SRS 的急性中枢神经系统毒性及生存。多因素分析显示WBRT与更差总生存及更高任何级别和2-4级毒性相关,而年龄≥80岁与毒性无关。作者建议在高龄患者中前瞻性评估SRS以最小化治疗相关毒性。
要点
- WBRT与更差总生存相关(OR 3.7, 95%CI 1.9-7.0, P<.0001)。
- WBRT与更高任何级别毒性相关(OR 7.5, 95%CI 1.6-33.3, P=.009)。
- WBRT与更高2-4级毒性相关(OR 2.8, 95%CI 1.0-8.1, P=.047)。
核心结论
- 在老年及高龄脑转移患者中,WBRT较SRS与更多毒性相关,应前瞻性评估SRS以最小化治疗相关毒性。
研究设计与样本
- 回顾性综述纳入2010至2015年Johns Hopkins医院119例老年(70-79岁)及高龄(≥80岁)脑转移患者,共811个脑转移灶接受RT,排除小细胞肺癌。
主要发现
- 从脑转移诊断起中位总生存WBRT组为4.3个月,SRS组为14.4个月。
- 多因素分析中WBRT与更差总生存相关(OR 3.7, 95%CI 1.9-7.0, P<.0001),年龄≥80岁则否。
- 多因素分析中WBRT与更高任何1-4级毒性(OR 7.5, 95%CI 1.6-33.3, P=.009)及2-4级毒性(OR 2.8, 95%CI 1.0-8.1, P=.047)相关。
- 按年龄分层,老年与高龄患者急性毒性率无统计学显著差异。
关键数值与推荐
- 急性中枢神经系统毒性采用RTOG急性放射中枢神经系统发病率量表于放疗后3个月内分级。
临床怎么用
- 对老年及高龄脑转移患者,考虑SRS而非WBRT以降低急性中枢神经系统毒性,但需前瞻性研究验证。
局限性
- 原文未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We evaluated the toxicity associated with stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) in elderly and very elderly patients with brain metastases, as the role of SRS in geriatric patients who would traditionally receive WBRT is unclear. METHODS AND MATERIALS: We conducted a retrospective review of elderly patients (aged 70-79 years) and very elderly patients (aged ≥80 years) with brain metastases who underwent RT from 2010 to 2015 at Johns Hopkins Hospital. Patients received either upfront WBRT or SRS for metastatic solid malignancies, excluding small cell lung cancer. Acute central nervous system toxicity within 3 months of RT was graded using the Radiation Therapy Oncology Group acute radiation central nervous system morbidity scale. The toxicity data between age groups and treatment modalities were analyzed using Fisher's exact test and multivariate logistic regression analysis. Kaplan-Meier curves were used to estimate the median overall survival, and the Cox proportion hazard model was used for multivariate analysis. RESULTS: A total of 811 brain metastases received RT in 119 geriatric patients. The median overall survival from the diagnosis of brain metastases was 4.3 months for the patients undergoing WBRT and 14.4 months for the patients undergoing SRS. On multivariate analysis, WBRT was associated with worse overall survival in this cohort of geriatric patients (odds ratio [OR] 3.7, 95% confidence interval [CI] 1.9-7.0, P<.0001) and age ≥80 years was not. WBRT was associated with significantly greater rates of any grade 1 to 4 toxicity (OR 7.5, 95% CI 1.6-33.3, P=.009) and grade 2 to 4 toxicity (OR 2.8, 95% CI 1.0-8.1, P=.047) on multivariate analysis. Elderly and very elderly patients did not have significantly different statistically acute toxicity rates when stratified by age. CONCLUSION: WBRT was associated with increased toxicity compared with SRS in elderly and very elderly patients with brain metastases. SRS, rather than WBRT, should be prospectively evaluated in geriatric patients with the goal of minimizing treatment-related toxicity.
引用
- Chen L, Shen C, Redmond KJ, et al. Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017. PMID: 28602418. doi:10.1016/j.ijrobp.2017.02.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。